Results 41 to 50 of about 97,768,553 (154)

Differences in the content of human milk oligosaccharides between foremilk and hind milk

Food Bioengineering, 2023
Human milk oligosaccharides (HMOs) are the second largest carbohydrate component and the third largest nutrient after lactose, and their content and composition are related to the genetic characteristics of the mother, lactation period, geography, and ...
Zhiping Pu, Zhaona Sun, Jun Liu, Jinyue Zhang, Mengdi Cheng, Lina Zhang, Peng Zhou   +6 more
doaj   +1 more source

Short communication: Genotype-phenotype association analysis revealed different utilization ability of 2'-fucosyllactose in Bifidobacterium genus [PDF]

, 2021
peer-reviewedThe oligosaccharide 2'-fucosyllactose (2'FL) in human breast milk selectively promotes the proliferation of bifidobacteria. One hundred fifty-one Bifidobacterium strains were evaluated for their capacity to utilize 2'FL based on the ...
Liu, Xiaoming, Chen, Wei, Ross, R. Paul, Stanton, Catherine, Yang, Bo, Zhao, Jianxin, He, Zhujun, Zhang, Hao   +7 more
core   +1 more source

The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites

Microorganisms, 2023
Human milk oligosaccharides (HMOs) shape the developing infant gut microbiota. In this study, a semi-continuous colon simulator was used to evaluate the effect of 2 HMOs—2′-fucosyllactose (2′-FL) and 3-fucosyllactose (3-FL)—on the composition of infant ...
Krista Salli, Johanna Hirvonen, Heli Anglenius, Ashley A. Hibberd, Ilmari Ahonen, Markku T. Saarinen, Johanna Maukonen, Arthur C. Ouwehand   +7 more
doaj   +1 more source

Bifidobacterium infantis and 2’-Fucosyllactose supplementation in early life may have potential long-term benefits on gut microbiota, intestinal development, and immune function in mice

, 2022
Bifidobacterium infantis and 2’-Fucosyllactose supplementation in early life may have potential long-term benefits on gut microbiota, intestinal development, and immune function in miceTHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE.
罗, 雅 (via Mendeley Data), 罗, 雅亭   +1 more
core   +1 more source

Synthesis of fucosyllactose using α-L-fucosidases GH29 from infant gut microbial metagenome [PDF]

Fucosyl-oligosaccharides (FUS) provide many health benefits to breastfed infants, but they are almost completely absent from bovine milk, which is the basis of infant formula.
Moya Gonzálvez, Eva M., Zeuner, Birgitte, Holck, Jesper, Yebra, María J., Palomino Schätzlein, Martina, Thorhallsson, Albert Th., Thorhallsson, Albert, Meyer, Anne S., Yebra, María Jesús, Palomino-Schätzlein, Martina, Rodríguez-Díaz, Jesús, Moya-Gonzálvez, Eva M., PalominYebra Yebra, María Jeso-Schätzlein, Martina, Rodríguez Díaz, Jesús   +13 more
core   +2 more sources

Research Progress in Metabolic Engineering Strategies for Microbial Synthesis of 2′-Fucosyllactose and 3-Fucosyllactose

Shipin gongye ke-ji
Human milk oligosaccharides (HMOs) are key components of breast milk, playing a vital role in fostering the healthy development of infants and young children.
Dengbin LI, Chao WEI, Yuan ZHANG, Genlin ZHANG, Xiaoyan WANG   +4 more
doaj   +1 more source

Baseline data of mother-infant pairs in the Low- and High 2’Fucosyllactose groups.

, 2017
Baseline data of mother-infant pairs in the Low- and High 2’Fucosyllactose groups.
Norbert Sprenger (368719), Philippe Steenhout (3738235), Sagar K. Thakkar (2967768), Le Ye Lee (3738238), Carlos Antonio De Castro (3738241)   +4 more
core   +1 more source

Production and characterization of Aspergillus niger GH29 family α-fucosidase and production of a novel non-reducing 1-fucosyllactose

, 2020
Fucosylated oligosaccharides are interesting molecules due to their bioactive properties. In particular, their application as active ingredient in milk powders is attractive for dairy industries.
Ruvalcaba Medrano, Marcela, Salminen, Heidi, Tossavainen, Olli, Usvalampi, Anne, Maaheimo, Hannu, Frey, Alexander D.   +5 more
core   +1 more source

"Microbial and immune modulation by 2'-fucosyllactose supplementation during gestation: a strategy to prevent food allergies". [PDF]

Gut Microbes
International audienceFood allergies are linked to dysfunction in intestinal microbiota, the immune system and the intestinal epithelial barrier, leading to immune tolerance failure at birth.
Brosseau C, Rousseaux A, Le Romancer M, Ropers MH, Lollier V, De Carvalho M, Barbarot S, Bodinier M.   +7 more
europepmc   +2 more sources

2’-Fucosyllactose alleviate immune checkpoint blockade-associated colitis by reshaping gut microbiota and activating AHR pathway

Food Science and Human Wellness
Immune checkpoint blockade (ICB) therapeutics are highly effective in cancer immunotherapy, but gastrointestinal toxicity limited the application. Intestinal microbiota plays a crucial role in ICB-associated colitis.
Shikai Yan, Leilei Yu, Fengwei Tian, Jianxin Zhao, Wei Chen, Qixiao Zhai   +5 more
doaj   +1 more source